BLISS GVS PHARMA LTD. | Scrip Code : 506197 | Quarter ending :June 2017 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | No | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 10 | 6,20,57,046 | 6,20,57,046 | 60.16 | 6,20,57,046 | 60.16 | 6,20,57,046 | - | - | - | (B) Public | 15,848 | 4,10,89,626 | 4,10,89,626 | 39.84 | 4,10,89,626 | 39.84 | 3,59,66,098 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | - | - | - | Grand Total | 15,858 | 10,31,46,672 | 10,31,46,672 | 100.00 | 10,31,46,672 | 100.00 | 9,80,23,144 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|